Adnexal masses in women with breast cancer
Background Adnexal masses detected in breast cancer survivors are of particular concern because of the increased risk of ovarian malignancy. Aims This study was performed to analyse adnexal masses among women with breast cancer with regard to variables predictive of malignancy. Methods The study inc...
Saved in:
Published in | Australian & New Zealand journal of obstetrics & gynaecology Vol. 52; no. 3; pp. 266 - 269 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Australia
Blackwell Publishing Ltd
01.06.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
Adnexal masses detected in breast cancer survivors are of particular concern because of the increased risk of ovarian malignancy.
Aims
This study was performed to analyse adnexal masses among women with breast cancer with regard to variables predictive of malignancy.
Methods
The study included women with breast cancer who had undergone surgery for an adnexal mass between 2002 and 2010 at Hacettepe University Hospital. A total of 45 consecutive women with a mean age of 47.3 years (range 25–76) were analysed retrospectively.
Results
Of 45 cases reviewed, benign ovarian pathology was found in 35 cases (77.8%) and malignant ovarian neoplasms were found in 10 cases (22.2%). A simple ovarian cyst was observed in 25 cases (71.4%) as the most common type of benign pathology. Of the 10 cases with malignancy, 5 (50%) had primary ovarian carcinoma, while the remaining five women had breast carcinoma metastases to the ovary. Complex mass at ultrasonography, increased CA 125 level and oestrogen receptor–negative tumour were found to be the significant predictors of ovarian malignancy.
Conclusions
Although an adnexal mass in a woman with breast cancer is most commonly a benign ovarian cyst, the overall risk of ovarian malignancy is increased with breast cancer. An adnexal mass with complex architecture detected by ultrasonography and high CA 125 level were the strongest risk factors associated with increased risk of malignancy. |
---|---|
Bibliography: | istex:CDDC75DA89384D047C2AB663C63504F25B3B7724 ArticleID:AJO1430 ark:/67375/WNG-S42T49CB-K ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0004-8666 1479-828X |
DOI: | 10.1111/j.1479-828X.2012.01430.x |